ABTA-funded researcher discovers a weakness in brain cancer cells

Printer Friendly

April 9, 2015

In a study published in Nature, a team of biologists at the Massachusetts Institute of Technology (MIT) and the Whitehead Institute for Biomedical Research describe how they found a subset of glioblastoma tumor cells over-express an enzyme that breaks down an amino acid. Without the enzyme - called GLDC - the brain tumor cells die due to buildup of toxic byproducts of metabolism. 

Lead author, Dr. Dohoom Kim, an ABTA-funded researcher, says blocking GLDC in glioblastoma cells may offer a new way to treat the cancer.

Read more about this study online